Proscillaridin A inhibits lung cancer cell growth and motility through downregulation of the EGFR-Src-associated pathway.

Tsai, Jeng-Yuan; Weng, Chia-Wei; Lai, Yi-Hua; Tsai, Meng-Fang; Chen, Hsuan-Yu; Chen, Jeremy Jw

Tsai, Jeng-Yuan; Weng, Chia-Wei; Lai, Yi-Hua; Tsai, Meng-Fang; Chen, Hsuan-Yu; Chen, Jeremy Jw.

Afiliación

Tsai JY; Institute of Biomedical Sciences, National Chung Hsing University Taichung, Taiwan.
Weng CW; Institute of Biomedical Sciences, National Chung Hsing University Taichung, Taiwan.
Lai YH; Institute of Medicine, Chung Shan Medical University Taichung, Taiwan.
Tsai MF; College of Medicine, China Medical University Taichung, Taiwan.
Chen HY; Rheumatic Diseases Research Center, China Medical University Hospital Taichung, Taiwan.
Chen JJ; Department of Biomedical Sciences, Dayeh University Changhua, Taiwan.

Am J Cancer Res ; 13(11): 5352-5367, 2023.

Article en En | MEDLINE | ID: mdl-38058797

Palabras clave

EGFR; Proscillaridin A; Src; lung adenocarcinoma; small GTPase

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Am J Cancer Res Año: 2023 Tipo del documento: Article País de afiliación: Taiwán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google